MedPath

Treatment of BV With First Deqularum and Then Direkt After Clindamycin

Phase 3
Conditions
Infection, Bacterial
Interventions
Drug: treatment of BV with first Deqularum and then direkt after with vaginal clindamycin
Registration Number
NCT04067531
Lead Sponsor
Skaraborg Hospital
Brief Summary

Treatment of BV with first deqularum cloride and then followed with clindamycin vaginal Cream.

Detailed Description

The hypoteses is that deqularum cloride takes away the biofilm so that clindamycin will kills the bacteria.

Cure rate will be followed up after 1 month and then after 6 month

Recruitment & Eligibility

Status
UNKNOWN
Sex
Female
Target Recruitment
50
Inclusion Criteria
  • healthy women with BV
Exclusion Criteria
  • women treated with antibiotics within 1 month

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
treatment of BVtreatment of BV with first Deqularum and then direkt after with vaginal clindamycinall patients be treated with first Deqularum then with clindamycin Cream,
Primary Outcome Measures
NameTimeMethod
cure of BV6 month

cure rate of BV

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Department of Ob/Gyn, Skaraborgshospital Skövde

🇸🇪

Skövde, Sweden

© Copyright 2025. All Rights Reserved by MedPath